expand/collapse risk warning

Trading financial products on margin carries a high risk and is not suitable for all investors. Ensure you fully understand the risks and take appropriate care to manage your risk.

Trading financial products on margin carries a high degree of risk and is not suitable for all investors. Please ensure you fully understand the risks and take appropriate care to manage your risk.

Your capital is at risk.


Novo Nordisk Stocks

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]



Why trade?



Why trade?

Novo Nordisk is one of the world's leading biopharmaceutical companies, specializing in diabetes care. With a market cap of 1.97T DKK, Novo Nordisk has cemented its position as a global leader in healthcare and pharmaceuticals.

The company offers an extensive range of innovative products to help people living with diabetes, obesity, and haemophilia manage their conditions effectively. Novo Nordisk has provided the healthcare industry with cutting-edge treatments, products, and services for over 90 years. Investors should take note of this titan in the pharmaceuticals space as a potential long-term growth opportunity.

Novo Nordisk has had an interesting price history since its inception in 1989. Its lowest price has ever gone was DKK kr. 16.80 back on 26th July 2002 and the highest price was recorded in May 2023 at DKK kr. 1175.60 - an increase of over 600%. This is a fantastic return for any investor, making Novo Nordisk a great stock to keep in your portfolio.

As a trader, it's important to keep track of these price movements and be ready to capitalize when the time is right. With careful analysis and timing, you could make a great return by investing in Novo Nordisk!

When considering trading the Novo Nordisk company, traders should also take into account its competitors. Among them are Sanofi-Aventis, Pfizer, Merck & Co., and Johnson & Johnson. All of these companies offer a variety of treatments for diabetes and other medical conditions, but each of them has its own advantages and drawbacks. So depending on the goal of the trader and their individual risk appetite, they should research each company carefully before making a decision.

Each one of these companies has something to offer traders who are considering trading Novo Nordisk and should be taken into account when researching the stock.

Swap long [[ data.swapLong ]] points
Swap short [[ data.swapShort ]] points
Spread min [[ data.stats.minSpread ]]
Spread avg [[ data.stats.avgSpread ]]
Min contract size [[ data.minVolume ]]
Min step size [[ data.stepVolume ]]
Commission and Swap Commission and Swap
Leverage Leverage
Trading Hours Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

  • Trade 24/5
  • Minimum margin requirements
  • No commission, only spread
  • Fractional shares available
  • Easy to use platform

*Other fees may apply.

Sign up


Events that affect Novo Nordisk's share prices?

+ -

Changes in legislation, policy or market trends that are relevant to Novo Nordisk can have a significant impact on its share prices. For instance, the release of new drugs, changes in government policies on health issues, or the introduction of a competitor's product into the market could all affect Novo Nordisk's share prices. Investors should monitor the news for any changes or developments that could affect Novo Nordisk's stock price before making any trades.

Additionally, any major announcements or changes in the company's management could also affect its share prices. Investors should keep a close eye on corporate news releases and financial reports to get a better understanding of how the company is doing and how its stock price may be affected.

Does Novo Nordisk pay dividends?

+ -

Novo Nordisk A and B shares of DKK 0.20 each paid a total dividend of DKK 12.40 in 2022, consisting of an interim dividend of DKK 4.25 and a final dividend of DKK 8.15 per share paid in August 2022 and March 2023 respectively.

Novo Nordisk has enjoyed a long history of paying dividends to its shareholders, making it an attractive option for long-term investors.

Who are the major shareholders of Novo Nordisk?

+ -

Novo Nordisk's major shareholder is Novo Holdings A/S, a Danish public limited liability company. This company is 100% owned by the Novo Nordisk Foundation and holds all of its A shares. As such, the Foundation has significant control over the direction of Novo Nordisk as it makes decisions related to dividends, investments, and other corporate activities.

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.


Capitalise on rising prices (go long)


Capitalise on falling prices (go short)


Trade with leverage
Hold larger positions than the cash you have at your disposal


Trade on volatility
No need to own the asset


No commissions
Just low spreads


Manage risk with in-platform tools
Ability to set take profit and stop loss levels